Francesco Chiani - Tecnologo TD III LV

Transcrição

Francesco Chiani - Tecnologo TD III LV
CURRICULUM VITAE
FORMATO EUROPEO
INFORMAZIONI PERSONALI
Francesco Chiani
Roma 6/4/1976
Italiana
Via Ginevra, 12 00015 Monterotondo
3491400979
[email protected]
ESPERIENZA PROFESSIONALE
Se dipendente CNR indicare:
N. MATRICOLA 14796
QUALIFICA TECNOLOGO
LIVELLO III
In ordine di data (da – a)
7/01/2015 – 2/05/2012
[Iniziare con le più recenti ed
elencare separatamente ciascun
incarico ricoperto]
Nome e indirizzo del datore di lavoro
Tipo o settore di attività
Funzione o posto occupato
Principali mansion e responsabilità
Page 1 - Curriculum vitae
di Chiani Francesco
Tecnologo III Livello
CNR-IBCN-EMMA/INFRAFRONTIER/IMPC campus Buzzati-Traverso Monterotondo
Via E. Ramarini, 32
Mouse Production EUCOMM/EUCOMMTools/IMPC
Produzione ad alta frequenza di ceppi murini mutanti
Produzione nuovi modelli murini mutanti per il progetto UE (FP7) EUCOMM Tools e il progetto
internazionale IMPC; “head manager” quality control e gestione colonie di nuovi modelli murini
mutanti prodotti. Produzione modelli murine mutanti ad alta frequenza tramite iniezione di
cellule staminali in blastocisti, DNA in pronuclei e tecnologia CRISP/CAS9. Perfusione,
preparazione, e dissezioni tessuti di modelli murine come richiesto dal progetto EUCOMMTools.
Responsabile gestione inserimento ed automatizzazione dei modelli murine prodotti nel
database imit’s (International microinjection tracking system) (Database del consorzio Supported
by the European Union (Project number: 223592))
Immissione linee mutanti nel circuito EMMA/INFRAFRONTIER/IMPC. Per info:
http://www.mousephenotype.org/about-ikmc/eucommtools
Sviluppo programmi software per l’analisi genotipica ad alta frequenza richiesta dai progetti in
corso. Vedi l’applicazione web EUDealer (disponibile attualmente solo all’interno del campus
all’indirizzo http://10.0.0.174:8080/hello/)
In ordine di data (da – a)
[Iniziare con le più recenti ed
elencare separatamente ciascun
incarico ricoperto]
Nome e indirizzo del datore di lavoro
Tipo o settore di attività
Funzione o posto occupato
Principali mansion e responsabilità
In ordine di data (da – a)
[Iniziare con le più recenti ed
elencare separatamente ciascun
incarico ricoperto]
Nome e indirizzo del datore di lavoro
Tipo o settore di attività
Funzione o posto occupato
Principali mansion e responsabilità
In ordine di data (da – a)
30/04/2012 – 2/05/2009
Assegnista di ricerca
CNR-IBC-EMMA
Mouse Production EUCOMM/EUCOMMTools/EUMODIC
Produzione ad alta frequenza di ceppi murini mutanti
Produzione nuovi modelli murini mutanti per il progetto UE (FP7) EUCOMM Tools, EUCOMM
EUMODIC, “head manager” quality control e gestione colonie di nuovi modelli murini mutanti
prodotti. Produzione modelli murini mutanti ad alta frequenza tramite iniezione di cellule
staminali in blastocisti, DNA in pronuclei. Perfusione, preparazione, e dissezioni tessuti di
modelli murine come richiesto dal progetto EUCOMMTools. Responsabile gestione inserimento
ed automatizzazione dei modelli murine prodotti nel database imit’s (International microinjection
tracking system) (Database del consorzio Supported by the European Union (Project number:
223592))
Immissione linee mutanti nel circuito EMMA/EUCOMM/EUCOMMTools/EUMODIC
Specializzazione informatica: Sviluppo software con linguaggi open source (Python e Django
Framework) per la costruzione di test genitipici ad alta frequenza delle linee murine da produrre
e prodotte nei progetti in corso.
1/2/2009 –30/04/2009
Ritenuta d’acconto Plaisant
Plaisant
Via E. Ramarini, 32
EUCOMM Mouse Production
Produzione ad alta frequenza di ceppi murini mutanti
produzione nuovi modelli murini mutanti per il progetto UE (FP7) EUCOMM quality control e
gestione colonie di nuovi modelli murini mutanti prodotti. Produzione modelli murine mutanti ad
alta frequenza tramite iniezione di cellule staminali in blastocisti
31/1/2009 –1/02/2007
[Iniziare con le più recenti ed
elencare separatamente ciascun
incarico ricoperto]
Assegnista di Ricerca
Titolare Assegno di Ricerca per il Settore Scientifico Disciplinare BIO/11 –Biologia molecolareTitolo della ricerca: “Effetti delle basse dosi di radiazioni ionizzanti sull’espressione genica in
cellule di mammifero”.
Nome e indirizzo del datore di lavoro
Università degli studi la Sapienza di Roma
Ple A. Moro 5, 00185 Roma
Fondi Agenzia Spaziale Italiana (ASI)
Ricerca di Base
Indagine azione di radiazioni ionizzanti e dei neutroni su cellule H.U.V.E.C. tramite Real Time
PCR, Microarrays, saggi luciferasi e saggi di legame dei fattori di trascrizione come C/EBP, Nfkb
e AP1 nell’ambito del progetto M.O.M.A. dell’ASI (Agenzia Spaziale Italiana). Nell’ambito del
Tipo o settore di attività
Funzione o posto occupato
Principali mansion e responsabilità
Page 2 - Curriculum vitae
di Chiani Francesco
progetto M.O.M.A. ho realizzato in collaborazione con il C.A.S.P.U.R. (Consorzio
interuniversitario per le applicazioni di supercalcolo per università e ricerca) il datatabase
“RADIATION GENES. Tramite MicroRNA Real Time PCR, microRNA arrays e Northern Blot ho
studiato il ruolo dei MicroRNA nelle biopsie di tumori tiroidei di pazienti donatori. Inoltre
sottoponendo cellule endoteliali primarie a radiazioni ionizzanti con dosi di interesse medico ho
condotto ricerche sul profilo di espressione dei microRNA ed il loro possibile ruolo nella risposta
alle radiazioni ionizzanti .
In ordine di data (da – a)
[Iniziare con le più recenti ed
elencare separatamente ciascun
incarico ricoperto]
Nome e indirizzo del datore di lavoro
Tipo o settore di attività
Funzione o posto occupato
Principali mansioni e responsabilità
31/10/2006 –31/1/2007
Titolare borsa di studio Cenci Bolognetti
Università degli studi la Sapienza di Roma
Ple A. Moro 5, 00185 Roma
Cenci Bolognetti
Ricerca di Base
Conclusione e pubblicazione produzione lavoro scientifico svolto durante il dottorato di ricerca
(vedi Istruzione e formazione)
ISTRUZIONE E FORMAZIONE
In ordine di data (da – a)
Nome e tipo d’istituto di istruzione o
formazione
Principali materie e competenze
professionali apprese
Certificato o diploma ottenuto
Livello nella classificazione nazionale
o internazionale
In ordine di data (da – a)
Nome e tipo d’istituto di istruzione o
formazione
In ordine di data (da – a)
Page 3 - Curriculum vitae
di Chiani Francesco
2003-2006
Dottorato in Genetica e Biologia Molecolare dell’Università “La Sapienza” di Roma.
Inizialmente l’organismo modello utilizzato nei miei esperimenti è stato S. cerevisiae, tramite il
quale ho appreso tutte le tecniche basilari di biologia molecolare, tra cui: clonaggi, Souther,
Northern e Western blotting, PCR, RT-PCR, primer extension oltre alle tecniche specifiche per
lo studio dei fenomeni molecolari in questo organismo modello come ad esempio: gene
disruption, saggi di silenziamento, saggi di inibitori delle deacetilasi istoniche, digestioni in vivo
con Mnasi, DNasi, endonucleasi, ad alta e bassa risoluzione. Come tecniche avanzate sono
specializzato in Chromatin Immunoprecipitation, e gel bidimensionali per lo studio della topologia
del DNA; Microarray; analisi di Real Time PCR sia Taqman che SybrGreen (sia per mRNA che
per MicroRNA). Ho lavorato con cellule in coltura come HeLa e linee primarie come HUVEC,
ed ho appreso anche su queste le tecniche di crescita, infezione, ed analisi degli acidi nucleici.
Ho esaminato variazioni del profilo di espressione di cellule H.U.V.E.C. sottoposte ad inibitori e
attivatori delle deacetilasi istoniche tramite Atlas array gene expression. Ho svolto analisi del
profilo di espressione delle Sirtuine su cheratinociti di pazienti psoriasici tramite RT-PCR in
collaborazione con l’istituto dermopatico dell’immacolata di Roma.
Dottorato in Genetica e Biologia Molecolare dell’Università “La Sapienza” di Roma.
Titolo tesi Dottorato: Molecular studies of Sir2p in S. cerevisiae: Relevance of
transcriptional silencing and DNA topology
Dottorato Ph.D.
2006
Abilitazione alla professione di Biologo conseguita presso l’Università di Viterbo “La Tuscia”.
2002-1996
Nome e tipo d’istituto di istruzione o
formazione
Principali materie e competenze
professionali apprese
Diploma di Laurea in Scienze Biologiche indirizzo Biomolecolare conseguito presso l’Università
di Roma “La Sapienza”.
Organismo modello utilizzato, S. cerevisae gene disruption, saggi di silenziamento, saggi di
inibitori delle deacetilasi istoniche, digestioni in vivo con Mnasi, DNasi, endonucleasi, ad alta e
bassa risoluzione. Come tecniche avanzate sono specializzato in Chromatin
Immunoprecipitation, e gel bidimensionali per lo studio della topologia del DNA. Studio della
topologia del DNA in vari mutanti della cromatina nel
silenziamento genico e
nell’invecchiamento.
Certificato o diploma ottenuto
Diploma di Laurea in Scienze Biologiche indirizzo Biomolecolare con il punteggio di 110/110
Titolo tesi diploma di laurea: EFFETTI DELLA PROTEINA SIR2 NELLA TOPOLOGIA DI
ELEMENTI DI DNA EXTRACROMOSOMALI IN Saccharomyces cerevisiae.
In ordine di data
2001
Università degli studi “La Sapienza” di Roma
Vincitore borsa di collaborazione per i laboratori di Genetica e Biologia Molecolare “la Sapienza”
di Roma (anno 2001)
In ordine di data (da – a)
Nome e tipo d’istituto di istruzione o
formazione
Principali materie e competenze
professionali apprese
Certificato o diploma ottenuto
Livello nella classificazione nazionale
o internazionale
1995
Scuole superiori Istituto Tecnico Commerciale (ITC) Michelangiolo (Roma)
Ragioneria applicata alla programmazione e al calcolo automatizzato
Diploma di maturità Ragioniere Programmatore (40/60)
ATTIVITÀ DI RICERCA
Attuali campi di ricerca
Recenti attività scientifiche
Page 4 - Curriculum vitae
di Chiani Francesco
Ricerca e sviluppo nuove tecniche pre la generazione di modelli murini transgenesi
Crispr/Cas9. Applicazione di nuovi modelli murini per lo studio di malattie genetiche umane.
Identificazione tramite microarray e realtime PCR di patway attivati da radiazioni ionizzanti con
dosi di interesse medico, silenziamento genico e nell’invecchiamento, MicroRNA nella
tumorigenesi e angiogenesi.
PRODOTTI DELLA RICERCA
Contributi in riviste indicizzate
[ISI Web of Science / Pubmed /
Scopus]
Sara Vincenti*, Nadia Brillante, Vincenzo Lanza, Irene Bozzoni, Carlo Presutti, Francesco
Chiani*, Marilena Paola Etna and Rodolfo Negri. (2010) HUVEC cells respond to radiation by
inducing the expression of pro-angiogenic microRNAs. *These authors contributed equally to
this work. Radiat Res. 2011 May;175(5):535-46
Francesco Chiani; Camilla Iannone; Rodolfo Negri; Daniele Paoletti, Mattia D’Antonio;Paolo
D'Onorio De Meo and Tiziana Castrignanò. (2009) Radiation Genes: a database devoted to
microarrays screenings of transcriptional modulation induced by ionizing radiation in mammalian
cells. Database, Vol. 2009, Article ID bap007
Di Felice F, Chiani F, Camilloni G. (2008) Nucleosomes represent a physical barrier for
cleavage activity of DNA topoisomerase I in vivo. Biochem J. 2008 Feb 1;409(3):651-6.
Cioci F, Di Felice F, Chiani F, Camilloni G.(2007).DNA protein interactions at the rRNA of
Saccharomyces cerevisiae. Ital J Biochem. 2007 Jun;56(2):81-90. Review.
Francesco Chiani, Francesca Di Felice and Giorgio Camilloni. (2006) SIR2 modifies histone
H4-K16 acetylation and affects superhelicity in the ARS region of plasmid chromatin in S.
cerevisiae. Nucl Ac Res 34:5426-37.
A.Mai, S.Massa, S.Lavu, R.Pezzi, S.Simeoni, R.Ragno, F.R.Mariotti, F. Chiani, G.Camilloni, and
D.A. Sinclair. Design syntesis, and biological evaluation of Sirtinol analogues as class III
histone/protein deacetylase (Sirtuin) Inhibitors. J. Med. Chem. 2005, 48, 7789-7795.
Brevetti
Ceppi murini trangenici prodotti dal 2009 ad oggi: 176
Lista:
Nome linea mutante
2310A2:A117030N02Rik
8430419L09Rik
Asxl1
Ccng1
Cidec
Cpeb4
Crxo1s
Cyth2(PSCD2)
Dnajc12
Emid1
Fgf11
Mtor (Frap1)
Furin
Gmeb2
Gna11
Hsf2bp
Ino80e (Ccdc95)
Mcf21
Mlh1
Mtg1
Nfkbid (Ayo7)
Nmnat1
Parvb
Sbds
Sema5b
Stx8
Wbp2
Wrnip
Eed
Mtch2
Cox10
Zfp667
Fastkd1
Tbc1d10a
Tln1
EPD0039_4_A01
Ube4a
1700081D17Rik (pebp4)
Col4a5
4432412L15Rik
Ibsp
Abhd10
FAM86 (5730409G15RIK)
Scamp1
Rbm4
Fam110b (H17Rik)
Mapk8ip2
EPD0176_4_F05
HEPD0526_4_C06
EPD0233_5_G04
EPD0230_4_A01
EPD0197_1_C05
HEPD0527_3_A10
EPD0146_4_A06
HEPD0530_1_B02
HEPD0528_5_B12
EPD0155_3_D10
EPD0230_5_B07
EPD0057_4_C10
EPD0021_2_H09
HEPD0534_4_B11
HEPD0534_1_D05
HEPD0538_2_C09
HEPD0538_1_A05
HEPD0527_4_B10
HEPD0539_2_E02
HEPD0518_2_A11
EPD0158_3_C03
HEPD0509_4_A04
Stag2
Page 5 - Curriculum vitae
di Chiani Francesco
riferimento ID
EPD0021_2_D11
EPD0192_1_D02
EPD0080_1_B11
HEPD0073_2_D06
EPD0116_3_D06
EPD0060_4_E10
EPD0114_4_A04
EPD0140_4_G06
EPD0176_1_C06
EPD0215_5_D11
EPD0214_1_A08
EPD0046_3_A11
EPD0127_1_A12
HEPD0516_5_A02
EPD0156_3_A04
HEPD0520_6_B03
EPD0177_2_H03
HEPD0516_3_C09
HEPD0522_4_D07
EPD0117_4_A05
EPD0100_4_A03
EPD0060_1_C04
EPD0087_5_C08
EPD0113_2_D05
EPD0140_2_F02
EPD0038_2_A04
EPD0037_2_G04
EPD0059_2_G04
EPD0103_4_B04
HEPD0522_1_C06
EPD0501_2_D12
EPD0145_5_C07
EPD0226_4_A03
EPD0021_1_F03
Fam134c (1300010M03Rik)
Dpp9
Hspa12a
Clstn3
Fabp1
Ccdc101
Abat
Efha2
Grpel1
Mphosph9
tipo mutazione
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
tecnologia utilizzata per la produzione
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
disponibilità nel circuito infrafrontier
Frozen material
Frozen material
Frozen material
N.D.
Frozen material
Frozen material
N.D.
N.D.
N.D.
Frozen material
Frozen material
N.D.
Frozen material
N.D.
Frozen material
Frozen material
Frozen material
Frozen material
Frozen material
N.D.
Frozen material
Frozen material
Frozen material
N.D.
Frozen material
Frozen material
Frozen material
Frozen material
N.D.
Frozen material
N.D.
N.D.
N.D.
Frozen material
Frozen material
N.D.
Frozen material
Frozen material
Frozen material
Frozen material
N.D.
Frozen material
N.D.
Frozen material
Frozen material
Frozen material
Frozen material
N.D.
Frozen material
N.D.
Frozen material
Frozen material
Frozen material
Frozen material
N.D.
N.D.
Frozen material
Zfp667
Fastkd1
Tbc1d10a
EPD0145_5_C07
EPD0226_4_A03
EPD0021_1_F03
Tln1
EPD0039_4_A01
Ube4a
EPD0176_4_F05
1700081D17Rik (pebp4)
HEPD0526_4_C06
Lista(continua):
Col4a5
EPD0233_5_G04
Nome linea
mutante
riferimento
ID
4432412L15Rik
EPD0230_4_A01
2310A2:A117030N02Rik
EPD0021_2_D11
Ibsp
EPD0197_1_C05
8430419L09Rik
EPD0192_1_D02
Abhd10
HEPD0527_3_A10
Asxl1
EPD0080_1_B11
FAM86 (5730409G15RIK)
EPD0146_4_A06
Ccng1
HEPD0073_2_D06
Scamp1
HEPD0530_1_B02
Cidec
EPD0116_3_D06
Rbm4
HEPD0528_5_B12
Cpeb4
EPD0060_4_E10
Fam110b
(H17Rik)
EPD0155_3_D10
Crxo1s
EPD0114_4_A04
Mapk8ip2
EPD0230_5_B07
Cyth2(PSCD2)
EPD0140_4_G06
Stag2
EPD0057_4_C10
Dnajc12
EPD0176_1_C06
Fam134c (1300010M03Rik)
EPD0021_2_H09
Emid1
EPD0215_5_D11
Dpp9
HEPD0534_4_B11
Fgf11
EPD0214_1_A08
Hspa12a
HEPD0534_1_D05
Mtor
(Frap1)
EPD0046_3_A11
Clstn3
HEPD0538_2_C09
Furin
EPD0127_1_A12
Fabp1
HEPD0538_1_A05
Gmeb2
HEPD0516_5_A02
Ccdc101
HEPD0527_4_B10
Gna11
EPD0156_3_A04
Abat
HEPD0539_2_E02
Hsf2bp
HEPD0520_6_B03
Efha2
HEPD0518_2_A11
Ino80e
(Ccdc95)
EPD0177_2_H03
Grpel1
EPD0158_3_C03
Mcf21
HEPD0516_3_C09
Mphosph9
HEPD0509_4_A04
Mlh1
HEPD0522_4_D07
Pcnxl3
HEPD0534_9_H10
Mtg1
EPD0117_4_A05
Ap3m1
HEPD0529_8_B05
Nfkbid
(Ayo7)
EPD0100_4_A03
Tfpt
EPD0177_1_G06
Nmnat1
EPD0060_1_C04
Casq1
EPD0240_3_B08
Parvb
EPD0087_5_C08
Golt1b
EPD0289_3_F11
Sbds
EPD0113_2_D05
Tsr2
EPD0203_4_E02
Sema5b
EPD0140_2_F02
Atn1
EPD0289_1_F08
Stx8
EPD0038_2_A04
Hpd
HEPD0539_3_C05
Wbp2
EPD0037_2_G04
ccdc93
HEPD0552_4_C09
Wrnip
EPD0059_2_G04
Gpr1
HEPD0551_8_C01
Eed
EPD0103_4_B04
Rgs13
HEPD0552_5_H08
Mtch2
HEPD0522_1_C06
Phyhip
HEPD0550_5_A08
Cox10
EPD0501_2_D12
Rabgap1
HEPD0553_3_H04
Zfp667
EPD0145_5_C07
Tor1a
EPD0289_4_A02
Fastkd1
EPD0226_4_A03
Scnn1b
HEPD0556_9_D10
Tbc1d10a
EPD0021_1_F03
Rab3ip
HEPD0556_3_B09
Tln1
Fgfr1op
EPD0039_4_A01
HEPD0550_7_C03
Ube4a
Spg20
1700081D17Rik
Ap3s2 (pebp4)
Col4a5
Cenpe
4432412L15Rik
Gfod2
Ibsp
Fyb
Abhd10
Igsf10
FAM86Zcchc4-B10
(5730409G15RIK)
Scamp1
Atg3
Rbm4
Becn1
Fam110b
(H17Rik)
Hipk2
Mapk8ip2
ric8b
EPD0176_4_F05
HEPD0548_1_H08
HEPD0526_4_C06
HEPD0556_5_B08
EPD0233_5_G04
HEPD0553_1_A09
EPD0230_4_A01
HEPD0549_5_E04
EPD0197_1_C05
HEPD0569_8_D07
HEPD0527_3_A10
HEPD0555_4_F11
EPD0146_4_A06
EPD0176_4_B10
HEPD0530_1_B02
HEPD0513_4_G06
HEPD0528_5_B12
EPD0168_1_H11
EPD0155_3_D10
HEPD0547_7_F08
EPD0230_5_B07
HEPD0556_4_C07
EPD0057_4_C10
HEPD0538_4_B06
EPD0021_2_H09
HEPD0508_2_A11
HEPD0534_4_B11
HEPD0550_6_C05
HEPD0534_1_D05
HEPD0529_5_B11
HEPD0538_2_C09
HEPD0510_2_A07
HEPD0538_1_A05
HEPD0555_3_G05
HEPD0527_4_B10
EPD0176_1_B10
HEPD0539_2_E02
EPD0117_2_A05
HEPD0518_2_A11
HEPD0542_1_C08
EPD0158_3_C03
EPD0157_3_C12
HEPD0509_4_A04
HEPD0551_7_C04
HEPD0534_9_H10
EPD0098_4_D04
HEPD0529_8_B05
EPD0103_4_B10
EPD0177_1_G06
HEPD0622_2_D11
EPD0240_3_B08
HEPD0617_6_G03
Stag2
Mllt3
Fam134c (1300010M03Rik)
WSB2
Dpp9
Avpi1
Hspa12a
Tex22
Clstn3
Ywhab
Fabp1
Rya3
(Bpifb3)
Ccdc101
Ddx43
Abat
Mrto4
Efha2
Haus3
(Poln)
Grpel1
Ttll12
Mphosph9
Zap70
Pcnxl3
Slc39a8
Ap3m1
Hsph1
Tfpt
Ppap2b
Casq1
MMRN1
Golt1b
BC017612
Tsr2
Tmco7
Atn1
Ptpn22
Hpd
Cab39l
EPD0289_3_F11
EPD0230_4_B11
EPD0203_4_E02
HEPD0636_7_D06
EPD0289_1_F08
EPD0203_5_C05
HEPD0539_3_C05
EPD0330_6_B12
ccdc93
Ccdc151
Gpr1
Fam53b
HEPD0552_4_C09
HEPD0634_2_D03
HEPD0551_8_C01
HEPD0667_7_D08
Rgs13
Napb
Phyhip
Map3k10
Rabgap1
Aldh3a1
HEPD0552_5_H08
HEPD0520_1_H07
HEPD0550_5_A08
HEPD0635_8_D03
Tor1a
Zfp61
Scnn1b
Fcgbp
HEPD0553_3_H04
EPD0629_2_G05
EPD0289_4_A02
HEPD0549_2_C02
HEPD0556_9_D10
EPD0378_3_E12
Rab3ip
Zdhhc5
Fgfr1op
Adam19
HEPD0556_3_B09
HEPD0667_1_B01
HEPD0550_7_C03
HEPD0536_5_C08
Spg20
Camk2b
Ap3s2
Rnd1
HEPD0548_1_H08
HEPD0667_4_A12
HEPD0556_5_B08
EPD0581_3_F11
Cenpe
Il31
HEPD0553_1_A09
EPD0629_1_G06
HEPD0549_5_E04
HEPD0622_7_A07
Gfod2
Pex1
Fyb
Ctso
Igsf10
Fstl1
Zcchc4-B10
Gpr177
(Wls)
Atg3
Pcx
Becn1
2610021K21Rik
Hipk2
Katnb1
ric8b
Zbtb1
Mllt3
Page 6 - Curriculum vitae
Mfsd8
WSB2
di Chiani Francesco
Ptpn22
Avpi1
Ptpn22
HEPD0569_8_D07
EPD0626_5_G04
HEPD0555_4_F11
HEPD0638_3_B07
EPD0176_4_B10
HEPD0637_2_A02
HEPD0513_4_G06
EPD0241_5_A07
EPD0168_1_H11
HEPD0526_7_A03
HEPD0547_7_F08
HEPD0636_3_B09
HEPD0556_4_C07
EPD0482_2_D07
HEPD0538_4_B06
HEPD0623_4_A06
HEPD0508_2_A11
EPD0203_5_A05
Tex22
Tsen15
HEPD0550_6_C05
EPD0203_5_D05
HEPD0529_5_B11
EPD0612_2_D01
Ywhab
Vps35
HEPD0510_2_A07
HEPD0767_7_C11
Rya3 (Bpifb3)
HEPD0555_3_G05
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
tipo mutazione
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
knockout-first
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
tecnologia
utilizzata
per la produzione
ES
cell blastocyst
injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell blastocyst injection
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell
cell blastocyst
blastocyst injection
injection
ES
ES cell blastocyst injection
N.D.
N.D.
Frozen material
Frozen material
N.D.
Frozen material
Frozen material
disponibilità
nel circuito infrafrontier/IMPC
Frozen
material
Frozen material
Frozen material
N.D.
Frozen material
N.D.
Frozen material
Frozen material
N.D. material
Frozen
N.D. material
Frozen
N.D.
Frozen material
material
Frozen
Frozen material
N.D.
N.D. material
Frozen
Frozen material
material
Frozen
N.D. material
Frozen
Frozen material
material
Frozen
Frozen material
N.D.
Frozen material
N.D.
Frozen material
material
Frozen
Frozen material
material
Frozen
N.D. material
Frozen
Frozen material
N.D.
Frozen material
N.D.
Frozen material
material
Frozen
N.D.
N.D.
Frozen material
material
Frozen
Frozen material
N.D.
Frozen material
N.D.
Frozen material
material
Frozen
N.D.
N.D.
Frozen material
material
Frozen
N.D. material
Frozen
N.D.
N.D.
N.D. material
Frozen
Frozen material
N.D.
Frozen material
material
Frozen
N.D. material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
N.D. material
Frozen
Frozen material
material
Frozen
N.D. material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
N.D. material
Frozen
Frozen material
material
Frozen
N.D.
N.D.
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
N.D.
N.D. material
Frozen
N.D. material
Frozen
Frozen material
N.D.
Frozen material
material
Frozen
Frozen material
material
Frozen
N.D. material
Frozen
N.D. material
Frozen
Frozen material
material
Frozen
N.D. material
Frozen
Frozen material
N.D.
N.D. material
Frozen
N.D.
N.D.
Frozen material
material
Frozen
N.D. material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
N.D. material
Frozen
Frozen material
material
Frozen
N.D. material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
N.D.
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
N.D.
Frozen material
material
Frozen
Frozen material
material
Frozen
Frozen material
material
Frozen
N.D.
N.D.
Frozen material
material
Frozen
Frozen material
knockout-first
ES cell blastocyst injection
N.D.
knockout-first
ES cell blastocyst injection
Frozen material
Pex1
HEPD0622_7_A07 knockout-first
ES cell blastocyst injection
Frozen material
Ctso
EPD0626_5_G04
knockout-first
ES cell blastocyst injection
Frozen material
Fstl1
HEPD0638_3_B07 knockout-first
ES cell blastocyst injection
Frozen material
Gpr177 (Wls)
HEPD0637_2_A02 knockout-first
ES cell blastocyst injection
Frozen material
Pcx
EPD0241_5_A07
knockout-first
ES cell blastocyst injection
Frozen material
2610021K21Rik
HEPD0526_7_A03 knockout-first
ES cell blastocyst injection
Frozen material
Lista(continua):
Katnb1
HEPD0636_3_B09 knockout-first
ES cell blastocyst injection
Frozen material
EPD0482_2_D07
knockout-first
ES cell blastocyst
injection
N.D.
Nome lineaZbtb1
mutante
riferimento
ID
tipo
mutazione
tecnologia
utilizzata
per la produzione
disponibilità
nel circuito infrafrontier/IMPC
Mfsd8
HEPD0623_4_A06
ES cell blastocyst injection
Frozen material
2310A2:A117030N02Rik
EPD0021_2_D11 knockout-first
Ptpn22
EPD0203_5_A05
ES cell blastocyst injection
Frozen material
8430419L09Rik
EPD0192_1_D02 knockout-first
Ptpn22
EPD0203_5_D05
Asxl1
EPD0080_1_B11 knockout-first
ES cell blastocyst injection
Frozen material
Tsen15
EPD0612_2_D01 knockout-first
Ccng1
HEPD0073_2_D06
ES cell blastocyst injection
N.D.
Vps35
HEPD0767_7_C11
Cidec
EPD0116_3_D06 knockout-first
ES cell blastocyst injection
Frozen material
Tsen34
EPD0474_3_C11
N.D. material
Cpeb4
EPD0060_4_E10 knockout-first
ES cell blastocyst injection
Frozen
Zbtb32
CEPD0006_1_B07
Knock in
Frozen material
Crxo1s
EPD0114_4_A04 knockout-first
ES cell blastocyst injection
N.D.
Acan
CEPD0018_4_B02
Knock in
Frozen material
Cyth2(PSCD2)
EPD0140_4_G06 knockout-first
ES cell blastocyst injection
N.D.
Hes5
CEPD0015_2_B01
Knock in
ES cell blastocyst injection
Frozen material
Dnajc12
EPD0176_1_C06 knockout-first
N.D.
CCL25
CEPD0015_3_D01
Knock in
Emid1
EPD0215_5_D11 knockout-first
ES cell blastocyst injection
Frozen material
Tsen54
EPD0903_4_C07
N.D. material
Fgf11
EPD0214_1_A08 knockout-first
ES cell blastocyst injection
Frozen
EPD0795_1_H02
Frozen material
MtorTacr1
(Frap1)
EPD0046_3_A11 knockout-first
ES cell blastocyst injection
N.D.
Sncaip
EPD0724_4_D01
Furin
EPD0127_1_A12 knockout-first
ES cell blastocyst injection
Frozen material
Ddx1
HEPD0633_8_F05
Frozen material
Gmeb2
HEPD0516_5_A02 knockout-first
ES cell blastocyst injection
N.D.
Entpd5
CEPD0027_3_A10
Knock in
Gna11
EPD0156_3_A04 knockout-first
ES cell blastocyst injection
Frozen material
Mia
CEPD0027_4_A10
Knock in
ES cell blastocyst injection
Frozen material
Hsf2bp
HEPD0520_6_B03 knockout-first
Spink8
CEPD0029_5_B10
Knock in
Ino80e
(Ccdc95)
EPD0177_2_H03 knockout-first
ES cell blastocyst injection
Frozen material
Sorl1
EPD0532_2_A01 knockout-first
Mcf21
HEPD0516_3_C09
ES cell blastocyst injection
Frozen material
Pbx2
CEPD0034_3_C08
Knock in
Mlh1
HEPD0522_4_D07 knockout-first
ES cell blastocyst injection
Frozen material
Ttll5
CEPD0022_8_A07
Knock in
Frozen material
Mtg1
EPD0117_4_A05 knockout-first
ES cell blastocyst injection
N.D.
Cldn7
CEPD0027_5_A01
Knock in
Nfkbid
(Ayo7)
EPD0100_4_A03 knockout-first
ES cell blastocyst injection
Frozen material
Rnaset2b
HEPD0886_8_C09
N.D. material
Nmnat1
EPD0060_1_C04 knockout-first
ES cell blastocyst injection
Frozen
Meis3
CEPD0042_2_G04
Knock in
ES cell blastocyst injection
Frozen material
Parvb
EPD0087_5_C08 knockout-first
2700060E02Rik
HEPD0545_3_H06
Frozen material
Sbds
EPD0113_2_D05 knockout-first
ES cell blastocyst injection
N.D.
Sncaip-Tm1b
EPD0724_4_D01
knockout-reporter
Crossing-CRE-deleter
strain
Sema5b
EPD0140_2_F02 knockout-first
ES
cell blastocyst injection
Frozen material
Slc6a2
HEPD0649_1_F02
Stx8
EPD0038_2_A04 knockout-first
ES cell blastocyst injection
Frozen material
Ddx1-Tm1b
HEPD0633_8_F05
knockout-reporter
Crossing-CRE-deleter
strain
Wbp2
EPD0037_2_G04 knockout-first
ES
cell blastocyst injection
Frozen material
Tacr1-Tm1b
EPD0795_1_H02
knockout-reporter
Crossing-CRE-deleter
strain
Wrnip
EPD0059_2_G04 knockout-first
ES
cell blastocyst injection
Frozen material
Sorl1-Tm1b
EPD0532_2_A01
knockout-reporter
Crossing-CRE-deleter
strain
Frozen material
Eed
EPD0103_4_B04 knockout-first
ES
cell blastocyst injection
N.D.
Sgca
CEPD0035_1_A10 knockout-first
Knock in
ES cell blastocyst injection
Frozen material
Mtch2
HEPD0522_1_C06
Scgb3a1
CEPD0044_5_B01
Knock in
Frozen material
Cox10
EPD0501_2_D12 knockout-first
ES cell blastocyst injection
N.D.
unbek(crygn)
EPD0203_2_C08 knockout-first
Zfp667
EPD0145_5_C07
ES cell blastocyst injection
N.D.
Pias3
CEPD0047_2_A10
Knock in
Frozen material
Fastkd1
EPD0226_4_A03 knockout-first
ES cell blastocyst injection
N.D.
Lztfl
CEPD0063_3_C11
Knock in
Tbc1d10a
EPD0021_1_F03 knockout-first
ES cell blastocyst injection
Frozen material
Chga
CEPD0071_1_A04
Knock in
Tln1
EPD0039_4_A01
knockout-first
ES cell blastocyst injection
Frozen material
Pyy
CEPD0036_1_A11
Knock in
Frozen material
Ube4a
EPD0176_4_F05 knockout-first
ES cell blastocyst injection
N.D.
Aqp3 (pebp4)
CEPD0068_2_A04 knockout-first
Knock in
ES cell blastocyst injection
Frozen material
1700081D17Rik
HEPD0526_4_C06
Eomes
CEPD0073_5_A06
Knock in
Col4a5
EPD0233_5_G04 knockout-first
ES cell blastocyst injection
Frozen material
Sds
CEPD0071_3_B02
Knock in
4432412L15Rik
EPD0230_4_A01 knockout-first
ES cell blastocyst injection
Frozen material
Spic
CEPD0063_4_A10
Knock in
Ibsp
EPD0197_1_C05 knockout-first
ES cell blastocyst injection
Frozen material
Polr2f
CEPD0039_1_A09 knockout-first
Knock in
Frozen material
Abhd10
HEPD0527_3_A10
ES cell blastocyst injection
N.D.
Msx2
CEPD0038_1_D01
Knock in
FAM86 (5730409G15RIK)
EPD0146_4_A06 knockout-first
ES cell blastocyst injection
Frozen material
Slc6a2-Tm1b
HEPD0649_1_F02
knockout-reporter
Crossing-CRE-deleter
strain
Frozen material
Scamp1
HEPD0530_1_B02 knockout-first
ES
cell blastocyst injection
N.D.
2700060E02Rik-Tm1b
HEPD0545_3_H06
knockout-reporter
Crossing-CRE-deleter
strain
Rbm4
HEPD0528_5_B12 knockout-first
ES
cell blastocyst injection
Frozen material
Tsen34Δ59-66
sigma
cas9_sgRNA2' knockout-first
small indel
Crispr/Cas9
tecnolology
N.D. material
Fam110b
(H17Rik)
EPD0155_3_D10
ES
cell blastocyst
injection
Frozen
Tsen34Δ?
sigma
cas9_sgRNA2' knockout-first
small indel
Crispr/Cas9
tecnolology
N.D. material
Mapk8ip2
EPD0230_5_B07
ES
cell blastocyst
injection
Frozen
Tsen34
Δ60-68
sigma
cas9_sgRNA2' knockout-first
small indel
Crispr/Cas9
tecnolology
N.D. material
Stag2
EPD0057_4_C10
ES
cell blastocyst
injection
Frozen
Tsen34
Δ64-69
sigma
cas9_sgRNA2' knockout-first
small indel
Crispr/Cas9
tecnolology
Fam134c
(1300010M03Rik)
EPD0021_2_H09
ES
cell blastocyst
injection
N.D.
Aldh8a1
CEPD0089_1_D01 knockout-first
Knock in
Dpp9
HEPD0534_4_B11
ES cell blastocyst injection
Frozen material
Aldh3a2
CEPD0081_1_C04
Knock in
Frozen material
Hspa12a
HEPD0534_1_D05 knockout-first
ES cell blastocyst injection
N.D.
Myh4
CEPD0086_1_D11 knockout-first
Knock in
Clstn3
HEPD0538_2_C09
ES cell blastocyst injection
Frozen material
Fabp1
HEPD0538_1_A05 knockout-first
ES cell blastocyst injection
Frozen material
Ccdc101
HEPD0527_4_B10 knockout-first
ES cell blastocyst injection
Frozen material
Abat
HEPD0539_2_E02 knockout-first
ES cell blastocyst injection
Frozen material
Efha2
HEPD0518_2_A11 knockout-first
ES cell blastocyst injection
N.D.
Grpel1
EPD0158_3_C03 knockout-first
ES cell blastocyst injection
N.D.
Contributi in volume
Mphosph9
HEPD0509_4_A04 knockout-first
ES cell blastocyst injection
Frozen material
Pcnxl3
HEPD0534_9_H10 knockout-first
ES cell blastocyst injection
Frozen material
Ap3m1
HEPD0529_8_B05 knockout-first
ES cell blastocyst injection
Frozen material
Tfpt
EPD0177_1_G06 knockout-first
ES cell blastocyst injection
N.D.
•INFRAFRONTIER-IMPC-IKMC
Meeting
in
Rome
(CNR
Headquarter),
Italy on December 2-4,
Contributi in atti di convegno
Casq1
EPD0240_3_B08 knockout-first
ES cell blastocyst injection
N.D.
Golt1b
knockout-first
ES cell
blastocyst injection
Frozen material
2013.EPD0289_3_F11
“INFRAFRONTIER-IMPC-IKMC
CNR
Monterotondo
Mouse Production:
outcomes for the
Tsr2
EPD0203_4_E02
knockout-first
ES cell blastocyst injection
N.D.
scientific
community”
Chiani
F,
Gambadoro
A,
Pasquini
M.
Doe
B.G,
Tocchini-Valentini
G.P.
Atn1
EPD0289_1_F08
knockout-first
ES cell blastocyst injection
Frozen material
(poster
presentation)
and (Organization team).
Hpd
HEPD0539_3_C05
knockout-first
ES cell blastocyst injection
N.D.
ccdc93
HEPD0552_4_C09 knockout-first
ES cell blastocyst injection
N.D.
Gpr1
HEPD0551_8_C01 knockout-first
ES cell blastocyst injection
Frozen material
•CNR-EBRI-EMBL-ICGEB
Monterotondo
Workshop
2010March
18-19.
“The European Mouse
Rgs13
HEPD0552_5_H08 knockout-first
ES cell blastocyst injection
N.D.
Phyhip
HEPD0550_5_A08
knockout-first
ES cell
blastocyst injection
material
Mutagenesis
Program
(EUCOMM) Doe B.
Gambadoro
A. Chiani F. andFrozen
Tocchini-Valentini
GP.
Rabgap1
HEPD0553_3_H04 knockout-first
ES cell blastocyst injection
Frozen material
(poster
presentation).
Tor1a
EPD0289_4_A02
knockout-first
ES cell blastocyst injection
N.D.
Scnn1b
HEPD0556_9_D10 knockout-first
ES cell blastocyst injection
Frozen material
Rab3ip
knockout-firstN. Brillante, V.
ES cell
blastocyst
injection
N.D. F. Chiani, R. Negri.
•M. HEPD0556_3_B09
P. Etna , S. Vincenti,
Lanza,
I. Bozzoni,
C. Presutti,
Fgfr1op
HEPD0550_7_C03 knockout-first
ES cell blastocyst injection
Frozen material
HUVEC
cells
respond
to
radiation
by
inducing
the
expression
of
pro-angiogenic
Spg20
HEPD0548_1_H08 knockout-first
ES cell blastocyst injection
Frozen material microRNAs.
Ap3s2
ES cell blastocyst injection
Frozen material
FISVHEPD0556_5_B08
2009(poster knockout-first
presentation)
Cenpe
HEPD0553_1_A09 knockout-first
ES cell blastocyst injection
Frozen material
Gfod2
HEPD0549_5_E04 knockout-first
ES cell blastocyst injection
Frozen material
•Chiani
F., Orecchia
A., Cesarini E., Avitabile
S.,Scarponi
C., Mai
A., Zambruno
Fyb
HEPD0569_8_D07
knockout-first
ES cell blastocyst
injection C., AlbanesiFrozen
material
Igsf10
knockout-first
cell blastocyst
injection
material
G., HEPD0555_4_F11
Camilloni G.,
Failla C.5) Sirtuins,ES the
NAD-dependent
Histone Frozen
deacetylases,
as new
Zcchc4-B10
EPD0176_4_B10
knockout-first
ES cell blastocyst injection
Frozen material
Therapeutic
targets
in
tumor
Angiogenesis.
50th
Annual
meeting
of
the
italian
cancer
society
Atg3
HEPD0513_4_G06 knockout-first
ES cell blastocyst injection
Frozen material
Becn1
EPD0168_1_H11
knockout-first
ES cell blastocyst injection
Frozen material
Page 7 - Curriculum vitae
Hipk2
HEPD0547_7_F08 knockout-first
ES cell blastocyst injection
Frozen material
ric8b
HEPD0556_4_C07 knockout-first
ES cell blastocyst injection
Frozen material
di Chiani Francesco
Mllt3
HEPD0538_4_B06 knockout-first
ES cell blastocyst injection
Frozen material
WSB2
HEPD0508_2_A11 knockout-first
ES cell blastocyst injection
Frozen material
Avpi1
HEPD0550_6_C05 knockout-first
ES cell blastocyst injection
Frozen material
Tex22
HEPD0529_5_B11 knockout-first
ES cell blastocyst injection
N.D.
Rnd1
EPD0581_3_F11
Il31
EPD0629_1_G06
Naples 6/9/2008.
•R, Amendola, E. Fratini, M. Piscitelli, D.E. Sallustio, M. Angelone, M. Pillon, F. Chiani, V.
Licursi, R. Negri. In Vivo Skin response after low dose of 14 MeV neutron irradiation. 7th
International Meeting on the Effects of Low Doses of Radiation in Biological Systems (LOWRAD
2008) Lisbon november 27-29, 2008.
•F. Chiani, C. Iannone, V.Lanza and R. Negri. Transcriptional modulation by xrays and neutron
irradiated human endothelial cells. 7th International Meeting on the Effects of Low Doses of
Radiation in Biological Systems (LOWRAD 2008) Lisbon november 27-29, 2008.
•F. Chiani, V. Lanza, C. Iannone and R. Negri “Microarrays and real time RT-PCR analysis of
transcriptional modulation in neutron irradiated human HUVEC endothelial cells.” III Congresso
Nazionale ISSBB(Società italiana di biomedicina e biotecnologia spaziale) “Verso l’esplorazione
umana della spazio” 2-3 Aprile 2008 UDINE (poster presentation).
•R, Amendola, E. Fratini, M. Piscitelli, D.E. Sallustio, M. Angelone, M. Pillon, F. Chiani, V.
Licursi, R. Negri. “In vivo transcriptome modulation after low dose of high energy neutron
irradiation.” III Congresso Nazionale ISSBB(Società italiana di biomedicina e biotecnologia
spaziale) “Verso l’esplorazione umana della spazio” 2-3 Aprile 2008 UDINE (oral presentation).
•F. Chiani, C. Iannone, M. D’antonio, T. Castrignanò and R. Negri “RADIATION GENES: a
database devoited to microarrays screenings of transcriptional modulation induced by ionizing
radiation in mammalian cells” III Congresso Nazionale ISSBB(Società italiana di biomedicina e
biotecnologia spaziale) “Verso l’esplorazione umana della spazio” 2-3 Aprile 2008 UDINE
(poster presentation).
•F. Chiani, Di Felice F., C. Michetti, G. Camilloni Chromatin dynamics, transcriptional and DNA
topoisomerase I in S. cerevisiae. SIB 2006 Riccione.
•Chiani F., Di Felice F., F. Cioci and G.Camilloni “Sir2 affect superhelicity of S. cerevisiae DNA
plasmids and acts as replicative silencer” International meeting “DNA topology in the global
regulation of genome functions: basic studies and clinical application” Bertinoro, (Italia) (poster
presentation).
•F.R. Mariotti, F. Chiani e G. Camilloni “Studi in vivo delle proteine SIR e della famiglia HST in S.
cerevisiae.” 6° Convegno FISV, Riva del Garda, (Italia) (oral presentation).
•Chiani F., Di Felice F. e. Camilloni G.“In Saccharomyces cerevisiae la proteina Sir2 può
funzionare come silenziatore della replicazione. 5° Convegno FISV, Rimini (Italia) (oral
presentation).
•F.Ciciriello, F.Di Felice, Chiani, S. Albertosi, C. Dello Russo e G. Camilloni“Studio in vivo delle
interazioni DNA-proteine nel locus dell’rDNA in S. cerevisiae.” 4° Convegno FISV, Riva del
Garda (Italia) (oral presentation).
Presenza meeting internazionali
Page 8 - Curriculum vitae
di Chiani Francesco
•EUCOMMTOOLS Progress Meeting Unterschleißheim, (Germany), May 27-28, 2014.
•IMPC (International Mouse Phenotype Consortium) Phenotyping Workshop Toronto 28-29
October 2013 (Canada).
•EUCOMMTOOLS Progress Meeting in Hinxton, (UK) June 10-11, 2013.
• EUCOMMTOOLS Workshop “Mouse Perfusion and Dissection” 7th April, 2013 Alicante (Spain).
•EUCOMMTOOLS Progress Meeting/EUCOMM Farewell (April 4, 2012) Munich (Germany).
•EUCOMMTOOLS Progress Meeting 18-19 December 2012 Munich (Germany)
•8th EMMAService Meeting, Monterotondo Rome, (Italy), Nov. 8-9, 2012
•EUCOMM/CREATE/EUCOMMTOOLS meeting 5-6 July, 2011 Rome (Italy)
•EUCOMM/EUCOMMTOOLS progress meeting 5-6 april 2011 Alicante (Spain).
•6th EMMAservice meeting: CNR, Monterotondo (Italy) October 13th – 14th, 2011.
•EUCOMM annual review meeting. Munich June, 28 2010 (Germany).
•EUCOMM Progress Meeting / EUCOMMTOOLS kick-off meeting October, 2010 Munich
(Germany).
•2nd EMMAservice meeting: CNR-IBC, Monterotondo / October 22nd - 23rd, 2009
•EUCOMM meeting 2009 Harwal (UK).
Libri
•
Traduttore di “Biologia Molecolare”, Robert F. Weaver Terza edizione, editore Mc Graw Hill.
(2005)
Curatele
• Commissione esami del corso di Ingengneria Genetica per la facoltà di Biotecnologie Università
“La Sapienza” di Roma (2007-2008) corso prof. Presutti, prof. Negri.
• Docenza Corso di aggiornamento “ L’ANALISI EPIGENETICA NELLA PATOLOGIA UMANA:
LE DEACETILASI ISTONICHE” presso ISTITUTO DERMOPATICO DELL’IMMACOLATA di
Roma (2006).
TRATTAMENTO DEI DATI
PERSONALI, INFORMATIVA E
Il D.Lgs 30/06/2003, n. 196 “Codice in materia di protezione dei dati personali” regola il trattamento dei dati
personali, con particolare riferimento alla riservatezza, all’identità personale e al diritto di protezione dei dati
personali; l’interessato deve essere previamente informato del trattamento.
La norma in considerazione intende come “trattamento” qualunque operazione o complesso di operazioni
concernenti la raccolta, la registrazione, l’organizzazione, la conservazione, la consultazione,
l’elaborazione, la modifica, la selezione, l’estrazione, il raffronto, l’utilizzo, l’interconnessione, il blocco, la
comunicazione, la diffusione, la cancellazione e la distruzione di dati, anche se non registrati in una banca
dati.
In relazione a quanto riportato, autorizzo il CNR al trattamento dei dati contenuti nel presente curriculum
vitae e nella documentazione della quale fa parte integrante, sollevandolo da ogni responsabilità e
autorizzandolo alla pubblicazione, sul sito web del CNR, della relazione inerente alle proprie ricerche svolte
nell’ambito del Progetto finanziato dal CNR. Inoltre acconsento all’aggiornamento delle informazioni
intranet che mi riguardano sia relative le pubblicazioni sia alle ricerche svolte.
CONSENSO
The Undersigned hereby authorises the CNR to utilize and store the personal sensitive data contained in
the attached Curriculum Vitae for the purposes of bilateral Joint research projects and within the
framework of the Data protection Act No. 196, dates 30 June 2003 as promulgated by the Italian
Government.
( barrare la casella)
Page 9 - Curriculum vitae
di Chiani Francesco
X
Si, acconsento

Documentos relacionados